GENE ONLINE|News &
Opinion
Blog

Coronavirus
COVID-19 Vaccine
Taiwan’s TTY Biopharm Company Signs COVID-19 Vaccine Deal with BioNTech for 30 Million Doses
2020-10-20
COVID-19 Inactivated Vaccine
Philippines Says Phase 3 Trial of Sinovac’s CoronaVac May Start in November
2020-10-19
COVID-19 Monoclonal Antibody
Lilly’s Coronavirus Antibody Treatment Hits Pause Button Over Potential Safety Issues
2020-10-16
COVID-19 COVID-19 Antibody
COVID-19: Eli Lilly Claims Efficacy, Seeks Speedy Emergency Use Authorization for Antibody Therapy
2020-10-09
COVID-19 Interferon
Interferons May Hold the Key to the Severity of COVID-19
2020-10-03
COVID-19 Antibody
COVID-19: Early Data Shows Regeneron’s Antibody Cocktail Curbs Virus, Speeds Recovery
2020-10-01
COVID-19 Vaccine
COVID-19: J&J’s Vaccine Candidate Registers Strong Immune Response in Early Trials
2020-09-29
COVID-19 Vaccine
FDA Halts Another Coronavirus Vaccine Trial
2020-09-29
COVID-19 qPCR
Pioneering Nanopore Sequencing-Based COVID Diagnostic Bags Emergency Use Approval
2020-09-27
COVID-19 Vaccine
Entering Late into the COVID-19 Vaccine Race, Could this Pharma Duo Measure up to Competition?
2020-09-06
COVID-19 Cas9
Scientists Further Powerful Gene Editing Tech’s Caliber with Rapid, Low Cost COVID-19 Diagnosis
2020-09-06
COVID-19 Rapid Test
COVID-19: USFDA Approves Abbott’s $5 Test, BinaxNOW™ for Rapid Diagnosis
2020-08-27
COVID-19
AstraZeneca Initiates Phase 1 Trial of COVID-19 Antibody Treatment in the UK
2020-08-26
COVID-19
USFDA Chief Apologizes For Overstating Benefits of Convalescent Plasma Therapy
2020-08-26
COVID-19
CureVac Shares Catapult 494% Following Successful IPO Debut
2020-08-18
1 … 5 6 7 8 9 … 13
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top